The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 ...

Thank you for standing by, and welcome to the Krystal Biotech First Quarter 2025 Earnings Call. At this time, all participants are on a listen-only mode. After the speakers' presentations, there will ...

Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ETCompany ParticipantsJeff Hawkins - President and CEOJeff ...

A whirlwind of sessions, keynotes, fireside chats, posters, and exhibitors ... LeMieux: What are some of the hot topics for this year? Siu: I will highlight the clinical trials that are being ...

Blackbaud , the leading provider of software for powering social impact, is excited to announce the return of its in-person K-12 user conference, happening in July 2026 in Boston. This event is ...

Boehringer Ingelheim today announces the start of the JADE Phase II clinical study (NCT06769048), investigating the efficacy and safety of BI 1584862 as a potential first-in-class treatment for ...

Science writer Eldrian Tho visited this year’s conference held in Liverpool, where several Imperial researchers presented ...

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...

With one of the most densely concentrated life sciences hubs in Europe, the Netherlands sets its sights on becoming a global ...

Siren Biotechnology Inc., pioneers of Universal AAV Immuno-Gene Therapy for Cancer, today announced that it will present new scientific data at the 2025 American Society of Gene and Cell Therapy ...

The companies Biohaven, MoonLake Immunotherapeutics, and AIRNA bagged the biggest biotech funding rounds overall in April ...